Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Polyphasic data support the splitting of Aspergillus candidus into two species; proposal of Aspergillus dobrogensis sp. nov

V. Hubka, A. Nováková, Ž. Jurjević, F. Sklenář, JC. Frisvad, J. Houbraken, MC. Arendrup, KM. Jørgensen, JPZ. Siqueira, J. Gené, M. Kolařík,

. 2018 ; 68 (4) : 995-1011. [pub] 20180215

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc18024353

Aspergillus candidus is a species frequently isolated from stored grain, food, indoor environments, soil and occasionally also from clinical material. Recent bioprospecting studies highlighted the potential of using A. candidus and its relatives in various industrial sectors as a result of their significant production of enzymes and bioactive compounds. A high genetic variability was observed among A. candidus isolates originating from various European countries and the USA, that were mostly isolated from indoor environments, caves and clinical material. The A. candidus sensu lato isolates were characterized by DNA sequencing of four genetic loci, and agreement between molecular species delimitation results, morphological characters and exometabolite spectra were studied. Classical phylogenetic methods (maximum likelihood, Bayesian inference) and species delimitation methods based on the multispecies coalescent model supported recognition of up to three species in A. candidus sensu lato. After evaluation of phenotypic data, a broader species concept was adopted, and only one new species, Aspergillus dobrogensis, was proposed. This species is represented by 22 strains originating from seven countries (ex-type strain CCF 4651T=NRRL 62821T=IBT 32697T=CBS 143370T) and its differentiation from A. candidus is relevant for bioprospecting studies because these species have different exometabolite profiles. Evaluation of the antifungal susceptibility of section Candidi members to six antifungals using the reference EUCAST method showed that all species have low minimum inhibitory concentrations for all tested antifungals. These results suggest applicability of a wide spectrum of antifungal agents for treatment of infections caused by species from section Candidi.

​Department of Biotechnology and Biomedicine Technical University of Denmark Kongens Lyngby Denmark

​Department of Botany Faculty of Science Charles University Prague Czech Republic 2​Laboratory of Fungal Genetics and Metabolism Institute of Microbiology of the Czech Academy of Sciences Prague Czech Republic

Department of Botany Faculty of Science Charles University Prague Czech Republic 2​Laboratory of Fungal Genetics and Metabolism Institute of Microbiology of the Czech Academy of Sciences Prague Czech Republic

​EMSL Analytical Inc Cinnaminson New Jersey USA

​Laboratory of Fungal Genetics and Metabolism Institute of Microbiology of the Czech Academy of Sciences Prague Czech Republic

​Laboratory of Fungal Genetics and Metabolism Institute of Microbiology of the Czech Academy of Sciences Prague Czech Republic 1​Department of Botany Faculty of Science Charles University Prague Czech Republic

​Unit of Mycology Statens Serum Institut Copenhagen Denmark

​Unit of Mycology Statens Serum Institut Copenhagen Denmark 7​Department of Clinical Microbiology Rigshospitalet Copenhagen Denmark 8​Department of Clinical Medicine University of Copenhagen Copenhagen Denmark

​Unitat de Micologia Facultat de Medicina i Ciències de la Salut IISPV Universitat Rovira i Virgili Reus Spain

​Unitat de Micologia Facultat de Medicina i Ciències de la Salut IISPV Universitat Rovira i Virgili Reus Spain 10​Laboratório de Microbiologia Faculdade de Medicina de SãoJosé do Rio Preto São José do Rio Preto Brazil

​Westerdijk Fungal Biodiversity Institute Utrecht The Netherlands

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc18024353
003      
CZ-PrNML
005      
20210324093855.0
007      
ta
008      
180709s2018 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1099/ijsem.0.002583 $2 doi
035    __
$a (PubMed)29458472
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Hubka, Vít, $d 1986- $7 mzk2016904736 $u 2​Laboratory of Fungal Genetics and Metabolism, Institute of Microbiology of the Czech Academy of Sciences, Prague, Czech Republic. 1​Department of Botany, Faculty of Science, Charles University, Prague, Czech Republic.
245    10
$a Polyphasic data support the splitting of Aspergillus candidus into two species; proposal of Aspergillus dobrogensis sp. nov / $c V. Hubka, A. Nováková, Ž. Jurjević, F. Sklenář, JC. Frisvad, J. Houbraken, MC. Arendrup, KM. Jørgensen, JPZ. Siqueira, J. Gené, M. Kolařík,
520    9_
$a Aspergillus candidus is a species frequently isolated from stored grain, food, indoor environments, soil and occasionally also from clinical material. Recent bioprospecting studies highlighted the potential of using A. candidus and its relatives in various industrial sectors as a result of their significant production of enzymes and bioactive compounds. A high genetic variability was observed among A. candidus isolates originating from various European countries and the USA, that were mostly isolated from indoor environments, caves and clinical material. The A. candidus sensu lato isolates were characterized by DNA sequencing of four genetic loci, and agreement between molecular species delimitation results, morphological characters and exometabolite spectra were studied. Classical phylogenetic methods (maximum likelihood, Bayesian inference) and species delimitation methods based on the multispecies coalescent model supported recognition of up to three species in A. candidus sensu lato. After evaluation of phenotypic data, a broader species concept was adopted, and only one new species, Aspergillus dobrogensis, was proposed. This species is represented by 22 strains originating from seven countries (ex-type strain CCF 4651T=NRRL 62821T=IBT 32697T=CBS 143370T) and its differentiation from A. candidus is relevant for bioprospecting studies because these species have different exometabolite profiles. Evaluation of the antifungal susceptibility of section Candidi members to six antifungals using the reference EUCAST method showed that all species have low minimum inhibitory concentrations for all tested antifungals. These results suggest applicability of a wide spectrum of antifungal agents for treatment of infections caused by species from section Candidi.
650    _2
$a antifungální látky $x farmakologie $7 D000935
650    _2
$a Aspergillus $x klasifikace $x účinky léků $7 D001230
650    _2
$a Bayesova věta $7 D001499
650    _2
$a DNA fungální $x genetika $7 D004271
650    _2
$a mikrobiální testy citlivosti $7 D008826
650    _2
$a mykologické určovací techniky $7 D016533
650    _2
$a fenotyp $7 D010641
650    12
$a fylogeneze $7 D010802
650    _2
$a sekvenční analýza DNA $7 D017422
655    _2
$a časopisecké články $7 D016428
700    1_
$a Nováková, Alena, $u 2​Laboratory of Fungal Genetics and Metabolism, Institute of Microbiology of the Czech Academy of Sciences, Prague, Czech Republic. $d 1955- $7 jo2003193188
700    1_
$a Jurjević, Željko $u 3​EMSL Analytical, Inc., Cinnaminson, New Jersey, USA.
700    1_
$a Sklenář, František $u 1​Department of Botany, Faculty of Science, Charles University, Prague, Czech Republic. 2​Laboratory of Fungal Genetics and Metabolism, Institute of Microbiology of the Czech Academy of Sciences, Prague, Czech Republic.
700    1_
$a Frisvad, Jens C $u 4​Department of Biotechnology and Biomedicine, Technical University of Denmark, Kongens Lyngby, Denmark.
700    1_
$a Houbraken, Jos $u 5​Westerdijk Fungal Biodiversity Institute, Utrecht, The Netherlands.
700    1_
$a Arendrup, Maiken C $u 6​Unit of Mycology, Statens Serum Institut, Copenhagen, Denmark. 7​Department of Clinical Microbiology, Rigshospitalet, Copenhagen, Denmark. 8​Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
700    1_
$a Jørgensen, Karin M $u 6​Unit of Mycology, Statens Serum Institut, Copenhagen, Denmark.
700    1_
$a Siqueira, João P Z $u 9​Unitat de Micologia, Facultat de Medicina i Ciències de la Salut, IISPV, Universitat Rovira i Virgili, Reus, Spain. 10​Laboratório de Microbiologia, Faculdade de Medicina de SãoJosé do Rio Preto, São José do Rio Preto, Brazil.
700    1_
$a Gené, Josepa $u 9​Unitat de Micologia, Facultat de Medicina i Ciències de la Salut, IISPV, Universitat Rovira i Virgili, Reus, Spain.
700    1_
$a Kolařík, Miroslav, $d 1978- $7 xx0234047 $u Department of Botany, Faculty of Science, Charles University, Prague, Czech Republic. 2​Laboratory of Fungal Genetics and Metabolism, Institute of Microbiology of the Czech Academy of Sciences, Prague, Czech Republic.
773    0_
$w MED00006002 $t International journal of systematic and evolutionary microbiology $x 1466-5034 $g Roč. 68, č. 4 (2018), s. 995-1011
856    41
$u https://pubmed.ncbi.nlm.nih.gov/29458472 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20180709 $b ABA008
991    __
$a 20210324093805 $b ABA008
999    __
$a ok $b bmc $g 1316484 $s 1021274
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2018 $b 68 $c 4 $d 995-1011 $e 20180215 $i 1466-5034 $m International journal of systematic and evolutionary microbiology $n Int. j. syst. evol. microbiol. (Print) $x MED00006002
LZP    __
$a Pubmed-20180709

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...